Evidence map›Paper›PMID 27803895›Full record

ArticleFrontiers in public health2016

Reduced Susceptibility to Extended-Spectrum β-Lactams in

Daniela Ceccarelli, Munirul Alam, Anwar Huq, Rita R Colwell

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Genomic and epidemiological insights into a non-toxigenic Vibrio cholerae O1 Ogawa from an autochthonous case in Brazil.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Iranian journal of pathology · 2026
    Article
  5. Genomic portrayal of emerging carbapenem-resistant El Tor variantAntimicrobial agents and chemotherapy · 2025
    Article
  6. Article
  7. Antimicrobial Resistance in Sub-Saharan Africa: A Comprehensive Landscape Review.The American journal of tropical medicine and hygiene · 2025
    Review
  8. mSphere · 2025
    Article
  9. Prevalence ofInternational journal of microbiology · 2025
    Article
  10. Article
  11. Prevalence and antimicrobial resistance of food safety related Vibrio species in inland saline water shrimp culture farms.International microbiology : the official journal of the Spanish Society for Microbiology · 2023
    Article
  12. Resistance ofFrontiers in pharmacology · 2023
    Review
  13. Article
  14. Insights into Carbapenem Resistance inInternational journal of molecular sciences · 2022
    Review
  15. Diagnosis, Management, and Future Control of Cholera.Clinical microbiology reviews · 2022
    Review
  16. Article
  17. Clinical and socio-environmental determinants of multidrug-resistant vibrio cholerae 01 in older children and adults in Bangladesh.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  18. Article
  19. Review
  20. Prevalence ofFrontiers in public health · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Daniela CeccarelliMaryland Pathogen Research Institute, University of Maryland , College Park, MD , USA.
Munirul AlamInternational Center for Diarrheal Disease Research, Bangladesh (icddr,b) , Dhaka , Bangladesh.
Anwar HuqMaryland Pathogen Research Institute, University of Maryland, College Park, MD, USA; Maryland Institute for Applied Environmental Health, University of Maryland, College Park, MD, USA.
Rita R ColwellMaryland Pathogen Research Institute, University of Maryland, College Park, MD, USA; Maryland Institute for Applied Environmental Health, University of Maryland, College Park, MD, USA; Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
University of Maryland, College Park · USInternational Centre for Diarrhoeal Disease Research · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-lactams are antibiotic molecules able to inhibit cell wall biosynthesis. Among other mechanisms, resistance in Gram-negative bacteria is mostly associated with production of β-lactamase enzymes able to bind and hydrolyze the β-lactam ring. Extended-spectrum β-lactamases extend this ability also to third- and fourth-generation cephalosporins, as well as to carbapenems and monobactams.

Indexed as

antibiotic resistanceaquatic environmentBangladeshcarbapenemscholeraclinical environmentextended-spectrum β-lactamsVibrio cholerae

Identifiers

PMID27803895
PMCPMC5067765
OpenAlexW2538826729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.